Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 3,026,184 | reported | 23 Feb 2026 | tx 14+16,911,927−6,175,380 |
| Immunovant, Inc. | 835,039 | reported | 01 Apr 2025 | tx 19+2,031,141 |
| Arbutus Biopharma Corp | 67,000 | reported | 23 May 2024 | tx 7+273,000 |
| Myovant Sciences Ltd. | 58,608 | reported | 23 Aug 2019 | tx 2+103,608 |
| Axovant Sciences Ltd. | 42,000 | reported | 15 Apr 2021 | tx 4+464,500 |
| Urovant Sciences Ltd. | 25,000 | reported | 09 Jul 2019 | tx 2+75,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 587,390 | 3.85 USD | |
| 23 Feb 2026 | SALE | Roivant Sciences Ltd. | 587,390 | 27.51 USD | |
| 19 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 1,400,000 | 3.85 USD | |
| 19 Feb 2026 | SALE | Roivant Sciences Ltd. | 1,400,000 | 27.42 USD | |
| 20 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 1,012,610 | 3.85 USD | |
| 20 Feb 2026 | SALE | Roivant Sciences Ltd. | 1,012,610 | 27.15 USD | |
| 19 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 1,400,000 | 0.00 USD | deriv |
| 23 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 587,390 | 0.00 USD | deriv |
| 20 Feb 2026 | EXERCISE | Roivant Sciences Ltd. | 1,012,610 | 0.00 USD | deriv |
| 24 Dec 2025 | OTHER | Roivant Sciences Ltd. | 64,891 | 22.47 USD | |
| 24 Dec 2025 | GIFT | Roivant Sciences Ltd. | 110,489 | 0.00 USD | |
| 23 Dec 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 175,380 | 22.45 USD | |
| 30 Jul 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 1,836,547 | 0.00 USD | |
| 30 Jul 2025 | GRANT_AWARD | Roivant Sciences Ltd. | 11,900,000 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 199,365 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 93,599 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Arbutus Biopharma Corp | 67,000 | 0.00 USD | deriv |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 120,400 | 0.00 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 50,167 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Arbutus Biopharma Corp | 55,000 | 0.00 USD | deriv |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 121,916 | 0.00 USD | |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 158,292 | 0.00 USD | deriv |
| 29 Sept 2022 | PURCHASE | Immunovant, Inc. | 20,000 | 5.81 USD | |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 225,632 | 0.00 USD | |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 339,296 | 0.00 USD | deriv |